Endocrine Gland Neoplasms
"Endocrine Gland Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the ENDOCRINE GLANDS.
| Descriptor ID |
D004701
|
| MeSH Number(s) |
C04.588.322 C19.344
|
| Concept/Terms |
Endocrine Gland Neoplasms- Endocrine Gland Neoplasms
- Endocrine Gland Neoplasm
- Neoplasm, Endocrine Gland
- Neoplasms, Endocrine Gland
Carcinoma of Endocrine Gland- Carcinoma of Endocrine Gland
- Endocrine Gland Carcinoma
- Carcinoma, Endocrine Gland
- Endocrine Cancer
- Cancer, Endocrine
- Cancers, Endocrine
- Endocrine Cancers
- Endocrine Gland Cancer
- Cancer, Endocrine Gland
- Cancer of Endocrine Gland
- Cancer of the Endocrine Gland
|
Below are MeSH descriptors whose meaning is more general than "Endocrine Gland Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Endocrine Gland Neoplasms".
This graph shows the total number of publications written about "Endocrine Gland Neoplasms" by people in this website by year, and whether "Endocrine Gland Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 2020 | 1 | 1 | 2 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Endocrine Gland Neoplasms" by people in Profiles.
-
NPY1R exerts inhibitory action on estradiol-stimulated growth and predicts endocrine sensitivity and better survival in ER-positive breast cancer. Sci Rep. 2022 02 04; 12(1):1972.
-
HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: Challenges and opportunities in genetic counseling for hereditary endocrine neoplasia syndromes. Endocr Relat Cancer. 2020 08; 27(8):T65-T75.
-
Surgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: A multidisciplinary approach. Surg Oncol. 2020 Sep; 34:182-185.
-
Phase II trial of pazopanib in advanced/progressive malignant pheochromocytoma and paraganglioma. Endocrine. 2017 Aug; 57(2):220-225.
-
American Joint Committee on Cancer: Endocrine Surgery. Ann Surg Oncol. 2017 May; 24(5):1151-1152.
-
A phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers. BMC Cancer. 2014 Aug 02; 14:561.
-
Endocrine tumors associated with neurofibromatosis type 1, Peutz-Jeghers syndrome and other familial neoplasia syndromes. Front Horm Res. 2013; 41:166-81.
-
The evolving field of tyrosine kinase inhibitors in the treatment of endocrine tumors. Endocr Rev. 2010 Aug; 31(4):578-99.
-
Succinate dehydrogenase gene mutations are strongly associated with paraganglioma of the organ of Zuckerkandl. Endocr Relat Cancer. 2010 Sep; 17(3):581-8.
-
MicroRNAs: a complex regulatory network drives the acquisition of malignant cell phenotype. Endocr Relat Cancer. 2010 Mar; 17(1):F51-75.